1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]butan-1-one
Chemical Structure Depiction of
1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]butan-1-one
1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]butan-1-one
Compound characteristics
| Compound ID: | P435-1760 |
| Compound Name: | 1-{4-[5-methyl-4-(morpholine-4-carbonyl)-1,3-oxazol-2-yl]piperidin-1-yl}-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]butan-1-one |
| Molecular Weight: | 507.59 |
| Molecular Formula: | C27 H33 N5 O5 |
| Smiles: | Cc1ccc(cc1)c1nc(CCCC(N2CCC(CC2)c2nc(C(N3CCOCC3)=O)c(C)o2)=O)on1 |
| Stereo: | ACHIRAL |
| logP: | 3.1898 |
| logD: | 3.1898 |
| logSw: | -3.1022 |
| Hydrogen bond acceptors count: | 10 |
| Polar surface area: | 89.886 |
| InChI Key: | CPXUTFGSOQDRTN-UHFFFAOYSA-N |